EZH2 and neuroblastoma: To test for the relevance of this interaction in our cell model, we used a WAD of neuroblastoma cells treated with the EZH2‐inhibitor GSK126 to extract a list of target genes of PRC2 (GSE85431, see list in Table S6) (Chen et al., 2018).